Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clinical Applications of Epidermal Stem Cells01:19

Clinical Applications of Epidermal Stem Cells

Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own EpiSCs...
Tissue Renewal without Stem Cells01:23

Tissue Renewal without Stem Cells

After cellular or tissue damage, the resident stem cells present in the human body can locally repair and regenerate the damaged tissue or organ. However, even though some tissues do not have stem cells, they can repair and regenerate with the help of pre-existing cells. For example, beta cells of the pancreas and hepatocytes of the liver can divide to renew and regenerate the tissue. Here, both cell division and cell death are well regulated by homeostasis.
However, failure of such a system...
Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
Renewal of Skin Epidermal Stem Cells01:12

Renewal of Skin Epidermal Stem Cells

The skin is divided into epidermis, dermis, and hypodermis, the skin's outermost, middle, and inner layers. The human epidermal layer regularly undergoes renewal, where old, dead cells are replaced by new cells. Epidermal stem cells or EpiSCs divide and differentiate to restore the lost cells. For the renewal process, some EpiSCs continuously self-renew. In contrast, few others differentiate into transit-amplifying cells, which later form prickle or spinous cells, followed by granular cells,...
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The human limbus functions as an instructive epithelial transition zone.

Research square·2026
Same author

Australasian consensus recommendations on stem cell therapies for managing ocular surface diseases.

The ocular surface·2026
Same author

In situ spatial transcriptomics reveals novel markers of the limbal stem cell niche and ocular surface epithelia.

Stem cell reports·2026
Same author

Development of a microscopy-based diagnostic test for alkali injury-induced limbal stem cell deficiency through Autofluorescence Multispectral Imaging.

Experimental eye research·2025
Same author

Mechanistic insights into conjunctivalization in limbal stem cell deficiency using a lineage tracing approach.

The ocular surface·2025
Same author

Single-Cell RNA Sequencing of Murine Limbal Epithelia Reveals Gas1 as a Novel Stem/Progenitor Cell Marker for the Corneal Epithelium.

Cornea·2025

Related Experiment Video

Updated: Jun 6, 2026

Combination of Microstereolithography and Electrospinning to Produce Membranes Equipped with Niches for Corneal Regeneration
11:42

Combination of Microstereolithography and Electrospinning to Produce Membranes Equipped with Niches for Corneal Regeneration

Published on: September 12, 2014

Tissue-regenerating, vision-restoring corneal epithelial stem cells.

Timothy Jerome Echevarria1, Nick Di Girolamo

  • 1Inflammation and Infection Research Centre, Department of Pathology, School of Medical Sciences, University of New South Wales, Sydney, 2052, Australia.

Stem Cell Reviews and Reports
|November 12, 2010
PubMed
Summary

Limbal stem cell deficiency (LSCD) impairs vision by damaging the cornea. Research explores identifying donor stem cell location and viability to improve LSCD treatments.

More Related Videos

Isolation and Identification of Limbal Niche Cells
10:11

Isolation and Identification of Limbal Niche Cells

Published on: October 27, 2023

Efficient and Scalable Directed Differentiation of Clinically Compatible Corneal Limbal Epithelial Stem Cells from Human Pluripotent Stem Cells
10:07

Efficient and Scalable Directed Differentiation of Clinically Compatible Corneal Limbal Epithelial Stem Cells from Human Pluripotent Stem Cells

Published on: October 24, 2018

Related Experiment Videos

Last Updated: Jun 6, 2026

Combination of Microstereolithography and Electrospinning to Produce Membranes Equipped with Niches for Corneal Regeneration
11:42

Combination of Microstereolithography and Electrospinning to Produce Membranes Equipped with Niches for Corneal Regeneration

Published on: September 12, 2014

Isolation and Identification of Limbal Niche Cells
10:11

Isolation and Identification of Limbal Niche Cells

Published on: October 27, 2023

Efficient and Scalable Directed Differentiation of Clinically Compatible Corneal Limbal Epithelial Stem Cells from Human Pluripotent Stem Cells
10:07

Efficient and Scalable Directed Differentiation of Clinically Compatible Corneal Limbal Epithelial Stem Cells from Human Pluripotent Stem Cells

Published on: October 24, 2018

Area of Science:

  • Ophthalmology
  • Regenerative Medicine
  • Stem Cell Biology

Background:

  • The cornea's integrity relies on corneal epithelial stem cells in the limbus for self-renewal.
  • Damage to the limbus compromises stem cell function, leading to limbal stem cell deficiency (LSCD).
  • LSCD causes corneal neovascularization and persistent epithelial defects, severely impairing vision.

Purpose of the Study:

  • To investigate methods for improving therapeutic options for limbal stem cell deficiency (LSCD).
  • To determine the residency and viability of donor stem cells on the recipient ocular surface.

Main Methods:

  • Review of current treatment options for LSCD, focusing on stem cell transplantation.
  • Exploration of autologous limbal tissue transplantation techniques.
  • Investigation into alternative stem cell sources for corneal epithelium regeneration.

Main Results:

  • Current LSCD treatments primarily involve stem cell transplantation, with challenges related to allogeneic and xenogeneic materials.
  • Focus is shifting towards autologous transplantation and exploring stem cells from other organs.
  • Understanding donor stem cell behavior is crucial for therapeutic advancement.

Conclusions:

  • Improving LSCD treatment requires precise identification of donor stem cell location and duration of viability.
  • Further research into stem cell behavior is essential for enhancing current therapeutic strategies for LSCD patients.
  • Exploring alternative stem cell sources holds promise for future LSCD therapies.